Condition: Type 1 Diabetes · Sponsor: SAb Biotherapeutics, Inc.
This is a Phase 2b, investigator- and participant-blinded, placebo-controlled, parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D).
This description comes directly from the study's public registry record.
Senior Manager Clinical Operations · 1-844-763-1890 · SAFEGUARD@sab.bio
Always discuss trial participation with your own doctor first.
| University of California San Francisco Benioff Children's Hospital | San Francisco, California, United States | Recruiting |
| San Jose Clinical Trials, LLC | San Jose, California, United States | Recruiting |
| University of Colorado - Barbara Davis Center for Diabetes | Aurora, Colorado, United States | Recruiting |
| University of Florida College of Medicine | Gainesville, Florida, United States | Recruiting |
| University of Miami - Gables One Tower | Miami, Florida, United States | Recruiting |
| Children's Healthcare of Atlanta (CHOA) - Center for Advanced Pediatrics | Atlanta, Georgia, United States | Recruiting |
| IUH - Riley Hospital for Children - Riley Outpatient Center - Pediatric Diabetes & Endocrinology | Indianapolis, Indiana, United States | Not Yet Recruiting |
| Harvard Medical School - Joslin Diabetes Center and Joslin Clinical (JDS) | Boston, Massachusetts, United States | Not Yet Recruiting |
| Children's Mercy Hospital Kansas City - Pediatric Care Clinic | Kansas City, Missouri, United States | Recruiting |
| University of New Mexico Hospital | Albuquerque, New Mexico, United States | Not Yet Recruiting |
| University at Buffalo MD Physicians Group | Buffalo, New York, United States | Recruiting |
| Asheville Clinical Research | Asheville, North Carolina, United States | Recruiting |
+ 59 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07187531